Zoetis (ZTS) Total Debt (2012 - 2026)
Zoetis' (ZTS) quarterly Total Debt came in at $9.0 billion in Q1 2026, up 37.52% year-on-year from $6.6 billion in Q1 2025, and little changed on a QoQ basis from $9.0 billion in Q4 2025.
Zoetis (ZTS) Total Debt (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Total Debt data on file, last reported at $9.0 billion in Q1 2026.
- On a quarterly basis, Total Debt rose 37.52% year-over-year to $9.0 billion in Q1 2026; TTM through Mar 2026 was $9.0 billion, a 37.52% increase from a year earlier, with the FY2025 full-year figure at $9.0 billion, up 37.63% from the prior year.
- Total Debt for Q1 2026 stood at $9.0 billion, roughly flat from $9.0 billion in the prior quarter.
- Over the last five years, Total Debt for ZTS reached as high as $9.0 billion in Q1 2026 and fell as low as $5.2 billion in Q3 2022.
- Historically, Total Debt has averaged $6.7 billion across 5 years, with a median of $6.6 billion in 2024.
- Across the five-year window, Total Debt dropped 27.38% in 2022 and jumped 37.63% in 2025, its largest moves.
- Year by year, Total Debt stood at $6.6 billion in 2022, then advanced by 0.15% to $6.6 billion in 2023, then climbed by 0.09% to $6.6 billion in 2024, then jumped by 37.63% to $9.0 billion in 2025, then increased by 0.03% to $9.0 billion in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $9.0 billion in Q1 2026, $9.0 billion in Q4 2025, and $7.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 198.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.05 Bn |
| Dec 31, 2025 | 9.04 Bn |
| Sep 30, 2025 | 7.07 Bn |
| Jun 30, 2025 | 6.58 Bn |
| Mar 31, 2025 | 6.58 Bn |
| Dec 31, 2024 | 6.57 Bn |
| Sep 30, 2024 | 6.57 Bn |
| Jun 30, 2024 | 6.56 Bn |
| Mar 31, 2024 | 6.59 Bn |
| Dec 31, 2023 | 6.56 Bn |
| Sep 30, 2023 | 6.55 Bn |
| Jun 30, 2023 | 6.56 Bn |
| Mar 31, 2023 | 6.56 Bn |
| Dec 31, 2022 | 6.55 Bn |
| Sep 30, 2022 | 5.21 Bn |
| Jun 30, 2022 | 5.22 Bn |
| Mar 31, 2022 | 6.58 Bn |
| Dec 31, 2021 | 6.59 Bn |
| Sep 30, 2021 | 6.59 Bn |
| Jun 30, 2021 | 7.19 Bn |